// App-Quantinova.ai

114 : A phase I/II study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): Dose escalation results.

Researchers

Presenter

  • Brandon Lau

Principal Investigators

  • Megan Crumbaker

  • Andrew On Wah Yam

  • Stefano Marastoni

  • Mathew Luckhurst

  • Aaron O'Grady

  • Brad Wouters

  • Anthony M. Joshua

Medical Centers

  • The Kinghorn Cancer Centre, St Vincents Hospital, Sydney, Australia

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • The Kinghorn Cancer Centre, Sydney, Australia

Locations

  • Australia

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Itraconazole

  • Canadiol

Outcome

  • N/A

Study Design

  • Simon'S Two Stage Design

  • Dose Escalation

  • Cohort

Phase

  • I/II

Study Id's

  • NCT03513211

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved